Sciflies: Making Science Happen Beta September 30, 2010
Posted by Dr. Bertalan Meskó in Community Site, science, Web 2.0.1 comment so far
Sciflies is the newest addition (No. 51) to my list of biomedical community sites.
SciFlies is a new model for funding scientific research that allows the general public to get involved in scientific research by making small donations resulting in financing research for projects just waiting to prove new ideas that work, but just lack the funding to get started. SciFlies is a qualified nonprofit and all donations are tax-deductible.
Plug-In Glucose Meter for the iPhone September 30, 2010
Posted by Dr. Bertalan Meskó in Health 2.0, Innovation, Mobile.5 comments
You may remember iBreath that allows users to take an alcohol breath test. Now here is a Plug-In Glucose Meter for the iPhone. No FDA approval yet though as the iPhone is not considered a medical device.
BGStar® and iBGStar™ have been designed by listening to the needs and desires of people with diabetes. Both products aim to integrate convenient, accurate and easy-to-use blood glucose management with decision-making support in everyday lives of people with diabetes. The ultra-compact iBGStar™ can be plugged into an iPhone® or iPod touch® and displays results on a full-color, touch screen. It can also be used separately for on-the-go testing. The specially-designed and simple iBGStar™ Diabetes Manager App will allow data to be easily managed and communicated to healthcare professionals.
Future of Screen Technology: Video September 29, 2010
Posted by Dr. Bertalan Meskó in Video, Visualization.2 comments
I can’t wait to live in this world. I really want to scroll news in the mirror while brushing my teeth.
And in case you haven’t seen the Microsoft’s Vision of the Future (Parody):
Swedish Collection of Medical Social Media Resources September 28, 2010
Posted by Dr. Bertalan Meskó in Health, Health 2.0, Medicine, Medicine 2.0, PeRSSonalized Medicine, Web 2.0, Webicina.2 comments
We launched PeRSSonalized Medicine to help patients and doctors keep themselves up-to-date easily. It’s the simplest, free, customizable medical information aggregator covering over 65 medical specialties and conditions in 16 languages!
The Swedish selection is the newest one in which the platform is in Swedish and the blogs, news sites, Twitter users and peer-reviewed journals are also the most relevant ones in that language. Please let us know if you want to see PeRSSonalized Medicine in your language.
Many thanks to Meybod Kia for the translation!
Some reasons why PeRSSonalized Medicine is unique:
- You can search in the database. It means you will find medical information only from a quality selected portion of the world wide web.
- You can personalize any of the sections.
- You can also receive the newest Pubmed articles focusing on your search term. Just insert your field of interest, a therapy, a condition, etc. and click Search. Then you can add the newly created box to your personalized medical “journal”.
- It is a community-based project. Please let us know which quality resources should be added to the database.
- Access over 65 medical topics in over 16 languages!
Interview about Webicina and Health 2.0 September 28, 2010
Posted by Dr. Bertalan Meskó in Blogging, Health 2.0, Interview, Medicine 2.0, Web 2.0.add a comment
Walter Jessen, PhD at the famous Highlight Health Blog did an interview with me about doing PhD in genomics, health 2.0, Webicina, Scienceroll and many other issues. Check it out on HighlightHealth. He also created a word cloud of my tweets:
Health and Sound: TED Talk September 28, 2010
Posted by Dr. Bertalan Meskó in Health, Ted Talks, Video.4 comments
Julian Treasure had an interesting talk about the relationship between the sounds around us and our health.
Julian Treasure says our increasingly noisy world is gnawing away at our mental health — even costing lives. He lays out an 8-step plan to soften this sonic assault (starting with those cheap earbuds) and restore our relationship with sound.
DocTweets: Streaming Twitter Chats Live September 27, 2010
Posted by Dr. Bertalan Meskó in Health, Health 2.0, Medicine, Medicine 2.0, twitter, Web 2.0.1 comment so far
I’ve recently come across DocTweets which has a great mission and a prestigious advisory board.
So just what is healthcare social media ‘street cred’, thought leadership or transformational modeling? What are the boundaries and potential applications of these technologies to the acknowledged shortfalls of the US healthcare system? Recently the Mayo Clinic announced an initial ‘Board of Advisors’ for their revolutionary and material commitment to innovation via their Center for Social Media. Shortly thereafter both Kevin Pho, MD aka KevinMD, and Bryan Vartebedian, MD, aka Doctor_V, opined that the initial list of ‘advisors’ was somewhat light on physician participation.
So the thought occurred, why not create an initial list of known physicians who ‘tweet’ i.e., engage (vs. solely push content) on Twitter. Couple this with Howard Luks, MD aka @hjluks previous query to the #hcsm (healthcare social media) community: is there a need for a ‘physician tweetchat?; and recent events suggest the answer to this question may be yes.
The Quantified Self: TED Talk September 27, 2010
Posted by Dr. Bertalan Meskó in Ted Talks, Video.add a comment
I’ve been a fan of the Quantified Self project for a long time and now a TED Talk describing their mission just became available.
Whole Genome Sequencing in Diagnostics? September 24, 2010
Posted by Dr. Bertalan Meskó in genetics, Genome, Personalized medicine.1 comment so far
Using whole genome sequencing in diagnostics has been an issue for years, and as the cost of sequencing is rapidly declining, it seems it can pave the way for personalized medicine. A new research published in Genome Biology, Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors, just proves this point:
Adenocarcinomas of the tongue are rare and represent the minority (20 to 25%) of salivary gland tumors affecting the tongue. We investigated the utility of massively parallel sequencing to characterize an adenocarcinoma of the tongue, before and after treatment.
We conclude that complete genomic characterization of a rare tumor has the potential to aid in clinical decision making and identifying therapeutic approaches where no established treatment protocols exist. These results also provide direct in vivo genomic evidence for mutational evolution within a tumor under drug selection and potential mechanisms of drug resistance accrual.
